VACC VACC

Vaccitech Share Price

2.32
-0.025 (-1.07%)
Upgrade to Real-Time
Afterhours (Closed)
2.32
Volume 34,526
Bid Price 2.33
Ask Price 2.59
News -
Company Name Stock Ticker Symbol Market Type
Vaccitech PLC VACC NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.025 -1.07% 2.32 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.44 2.30 2.44 2.32 2.345
Trades Volume VWAP Dollar Volume Avg Volume
216 34,526  2.36  81,392 -
Last Trade Time Type Quantity Stock Price Currency
16:09:41 1  2.29 USD

Period:

Draw Mode:

Vaccitech PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 86.53M 37.30M 35.74M  268.00k  79.27k -1.60 7.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - 334.00k 4.20%

more financials information »

News Vaccitech

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

VACC Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current prophylactic programs include VTP-400. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca.